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Abstract
Epimetabolites distinct from canonical metabolisms are identified by integrating three 
cheminformatics tools: BinVestigate, querying the BinBase GC-MS metabolome database to 
match unknowns with biological metadata across over 110,000 samples; MS-DIAL 2.0, a 
universal software for chromatographic deconvolution of high resolution GC- or LC-mass 
spectrometry; and MS-FINDER 2.0, a structure elucidation program with searching against an 
enzyme promiscuity library. The discoveries are showcased by N-methyl-alanine, N-methyl-UMP, 
lyso-monogalactosyl-monopalmitin, and two propofol derivatives.
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Untargeted metabolomics detects many more unknown peaks than identified compounds 
because publicly available mass spectra libraries are still very small in comparison to the 
chemical sphere of more than 68 million known compounds1. Even in GC-MS where the 
spectra have been collected systematically and in a standardized manner in the NIST and 
Wiley libraries for more than 30 years with over 267,000 unique compounds, only about 
40% of the reliably detectable peaks are identified in metabolomic profiles. This ‘dark 
matter of metabolomics’2 can be explained by at least five routes: (a) lack of knowledge of 
enzymatic transformations3, including substrate promiscuity4; (b) metabolic damage by 
spontaneous reactions or enzyme errors5; (c) signatures of exogenous compounds, for 
example from environmental sources6; (d) combined metabolic impact of a community of 
species, for example by gut microbiota7; and (e) formation of chemical artifacts during 
analytical protocols8. Recently, the new term ‘epimetabolite9’ was suggested to encompass 
such modified metabolites from the routes of (a) to (d) that gain physiological functions, 
similar to post-translational modifications of proteins. The purpose of this study is to 
identify novel epimetabolites from unknown chromatographic peaks, and the best strategy 
aims at reducing the number of important (functional) unknowns by investigating multiple 
studies simultaneously, including cross species analyses10. Once the origin, relevance and 
specificity of these unknowns have been asserted, accurate mass spectrometry and 
cheminformatics tools can be used to annotate and validate chemical structures.
We here present a unified method for functional and structural annotation of unknown 
epimetabolites (Fig. 1). BinBase is a large GC-MS based untargeted metabolomics database 
encompassing 1,561 studies with 114,795 samples for various species, organs, matrices, and 
experimental conditions that have been acquired over the past 13 years11. In BinBase, 9,563 
unique metabolites have been discovered so far, where 1,020 have been identified by mass 
spectral libraries of authentic standards12, in addition to 256 known chemical artifacts. To 
query biological metadata for each metabolite, BinVestigate (http://
binvestigate.fiehnlab.ucdavis.edu/) yields open access information about the abundance, 
frequency, species and organ origin. Once the importance of unknowns is evaluated, MS-
DIAL 2.0 (http://prime.psc.riken.jp/) is utilized to obtain the deconvoluted spectra from high 
resolution GC-MS data as prerequisite for compound identification. MS-DIAL was 
previously developed for LC-MS data processing13 but now enables processing both LC-
MS/MS and GC-MS data. Finally, again for either accurate mass GC-MS or LC-MS/MS, 
unknowns are annotated by their elemental formulas and in silico mass spectral 
fragmentation through MS-FINDER14 2.0 (http://prime.psc.riken.jp/). MS-FINDER 
integrates structures and formulas for 224,622 known metabolites and now also includes 
643,307 hypothetical compounds from the enzyme promiscuity database – MINE-DB 
(http://minedatabase.mcs.anl.gov/)15. Notably, MS-DIAL 2.0 links mass spectra directly to 
BinVestigate and MS-FINDER 2.0 while the tools are also available as stand-alone software. 
We give five successful examples for this strategy, ranging from new methylation products in 
mammalian and microbial cells to plant-specific metabolites and transformations of 
exposome compounds. The performances of three programs, including false discovery rates 
in BinBase, are discussed in Online Methods.
BinVestigate is used to query unknowns from different West Coast Metabolomics Center 
(WCMC) metabolomics studies and to prioritize and select targeted unknowns for structural 
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identification based on their cross-study specificity and relevance (Online Methods). The 
WCMC quality controls keep absolute signal intensities within two-fold deviations from the 
mean and avoid detector saturations, making intensities comparable across species and 
sample types. Therefore, besides frequency of detection in specific organs and species, 
BinVestigate uses average signal intensities to highlight relevance across studies. As the first 
case, unknown BinBase metabolite (BB160842) was detected in 44,128 samples (Fig. 2a), 
90% of which were from microbial, fecal, or plasma studies. It was found at 5–10 times 
higher signal intensity in human or animal fecal matter compared to microbial cells, and up 
to 20-fold higher than in body fluids or tissues. It suggests a compound of microbial origin 
that is excreted into human plasma. The second example, BB106699 was detected in 7,228 
samples, most abundantly in diverse cancer cell lines and cancer tissues (Fig. 2b). It showed 
up to 100-fold higher signal intensity in myeloma cancer cell lines compared to other cell 
types, such as mouse kidney cells. This compound was never found in fecal matter or 
bacterial samples, supporting the notion that it might be exclusive for eukaryotes and might 
have a specific role in cancer. Similarly, BB21735 (Supplementary Fig. 1) was found 
exclusively in 765 samples of algae, marine- and cyanobacteria, and plants but never in 
human or animal samples, suggesting a dedicated role in the biochemistry of photosynthetic 
organisms. Finally, BB171284 and BB118961 were found in only two clinical cohort studies 
in plasma and urine of 405 and 242 samples, respectively. As both studies involved 
pharmaceutical treatments, these compounds appeared to be significant for phase 2 drug 
clearance.
For identifying these unknown compounds, we first obtained high resolution (HR) accurate 
mass GC-MS data with different ionization techniques, and employed LC-MS/MS for 
validation. Unlike LC-MS/MS metabolomics, GC-MS based analyses lead to extensive 
fragmentation right at the source of ionization, even under soft chemical ionization. We have 
therefore developed a new version of our data processing software MS-DIAL. MS-DIAL 2.0 
is the first universal program for processing untargeted metabolomics data including spectral 
deconvolution and compound identification (Supplementary Figs. S2, S3, Supplementary 
Data 1, and Online Methods), supporting multiple MS data types (low or high resolution 
MS, and GC-MS, LC-MS, or LC-MS/MS) of any major vendor- or open data formats 
(Supplementary Fig. S4). By using MS-DIAL 2.0, the deconvoluted spectra from GC-HR-
MS and LC-HR-MS/MS were extracted from the representative biological samples 
containing the unknown metabolites discovered in BinVestigate.
The next step is MS-FINDER 2.0 for the structure elucidation of unknown HR-MS spectra, 
and we use BB106699 as a showcase (Fig. 3, Supplementary Figs. S5, S6, and Online 
Methods). First, the molecular adduct ion was identified to pursue the chemical formula of 
the unknown compound. As often observed for trimethylsilylated (TMS)-metabolites in GC-
MS, the molecular ion ([M] +•) was absent from the hard electron ionization spectrum. Its 
initial methyl cleavage fragment ion ([M-CH3]+) was found to be very low abundant, 
impeding the calculation of the elemental formula for this unknown (Fig. 3a). We have 
therefore used softer methane chemical ionization GC-HR-MS that yielded a pattern of 
additional highly characteristic molecular adduct ions. For BB106699, the molecular mass 
was calculated as 626.212 Da based on the alignment of ions at m/z 611.118 ([M-CH3]+), 
m/z 627.214 ([M+H]+), m/z 655.244 ([M+C2H5]+), and m/z 667.245 ([M+C3H5]+). MS-
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FINDER 2.0 calculated C10H15N2O9P as most probable elemental formula by the optimized 
algorithm for TMS-derivatives, using both heuristic and chemical rules14 (Fig. 3b). The 
formula was further validated by comparing regular TMS derivatization to stable isotope 
labeled d9-TMS. This comparison directly yielded the number of TMS groups, i.e., the 
number of acidic protons in the unknown molecule (Fig. 3b left). Hence, the fact that GC-
MS based metabolomics needs derivatization gave us the advantage to omit isomeric 
structures of C10H15N2O9P with less than four acidic protons. Moreover, comparing the 
chemical derivatization results by methoximation versus ethoximation showed that the 
unknown compound had no aldehyde or ketone functional groups16. In subsequent LC-HR 
MS/MS analysis, the formula was validated using both accurate mass and natural isotope 
abundance information (Fig. 3b right). In an analogous manner, formulas were confirmed as 
C4H9NO2 for BB160842 with 2 acidic protons, C25H48O9 for BB21735 with 5 acidic 
protons, and BB171284 and BB118961 as isomers of C18H26O8 with 5 acidic protons 
(Supplementary Table 1).
Using the elemental formulas, all potential isomer structures were retrieved from databases 
for these five unknown BinBase metabolites. For retrieving structure candidates, MS-
FINDER 2.0 uses a combination of 14 metabolomics databases comprising 47,311 formulas 
and 224,622 unique known structures. Yet, enzyme promiscuity and general lack of 
knowledge about enzyme reactions may be the reason of many unknown compounds. 
Therefore, MS-FINDER 2.0 also incorporates all MINE-DB structures15, a collection of 
643,307 virtual metabolites that are predicted based on generalized enzymatic 
transformations as applied to KEGG pathway metabolites.
For BB106699, C10H15N2O9P yielded 6 isomers from the 14 metabolomic databases in MS-
FINDER 2.0, and 33 isomers in MINE-DB. All structures were subsequently ranked by 
matching the experimental spectrum against predicted spectra for all isomers, considering 
chemical substructures recognized from the mass spectra as well as biochemical likelihood. 
For annotating chemical substructures from GC-MS spectra, MS-FINDER 2.0 exploits 228 
true-positive fragmentation patterns from 80 reports that were published over the past 50 
years17. These rules confirmed the presence of hydroxyl groups and a phosphate moiety in 
BB106699, a secondary amine and a carboxylic acid in BB160842, glycosylation of 
BB21735, and glucuronidation for BB171284 and BB118961 (Supplementary Table 1).
The unknown BB106699 was finally identified as N-methyl-UMP, a MINE predicted 
metabolite that has never been reported from biological samples. It ranked as the most likely 
structure in MS-FINDER 2.0 (Fig. 3c top) with all fragment ions rationalized by 
substructure annotations (Fig. 3c bottom). We validated the identification of N-methyl-UMP 
by synthesizing an authentic standard (Online Methods) and compared retention times and 
mass spectra in both GC-MS and LC-MS/MS to alternative O-methyl-UMP isomers 
(Supplementary Fig. S7). In the same manner, we annotated BB160842 as N-methyl-alanine 
(Supplementary Fig. S8), BB21735 as lyso-monogalactosylmonopalmitin (Supplementary 
Fig. S9), BB171284 as 4-hydroxypropofol-1-glucuronide (Supplementary Fig. S10), and 
BB118961 as 4-hydroxypropofol-4-glucuronide (Supplementary Fig. S11).
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In summary, open access metabolomics repositories such as the NIH 
MetabolomicsWorkbench18 and EBI MetaboLights19 are important for comparing 
metabolomic results with respect to identified compounds. However, for comparing 
unknown metabolites across different biological studies, it is critical to standardize data 
acquisition methods and data processing parameters. At current, only GC-MS (and, in 
principle, NMR) data fulfill this criterion. Our strategy fully utilizes this advantage, using 
MS-DIAL 2.0 with BinVestigate and MS-FINDER 2.0 that outperformed alternative 
deconvolution and compound identification software in untargeted metabolomics 
(Supplementary Tables 1 and 2). Moreover, our approach found e.g. N-methyl-UMP to be 
highly upregulated in cancer cells and cancer tissues, in comparison to any other cell type or 
tissue. Recently, methylation of small molecules has been shown to directly regulate cellular 
progression in stem cells20, raising the possibility of related mechanisms in cancer cells or 
utilizing methylated metabolites as cancer biomarkers. More broadly, it has been shown 
quite regularly that small chemical alterations of metabolites may remove these compounds 
from primary biochemistry pathways, and that such modified metabolites, i.e. 
epimetabolites, subsequently gain regulatory functions, for example oxylipins. For the 
discovery of epimetabolites, the integration of BinVestigate, MS-DIAL, and MS-FINDER 
provides a systematic strategy to utilize the complete set of mass spectral information as 
well as biochemical metadata to successfully find and rank the most likely chemical 
structures, and it would form the basis for a unified and standardized input for a 
comprehensive metabolomics repository.
Online Methods
BinBase
BinBase is a large GC-TOF MS based metabolomics database encompassing 1,561 studies 
with 114,795 samples for various species, organs, matrices, and experimental conditions. By 
the physics of GC-MS, analysis is restricted to thermostable small molecules that range up 
to 650 Da in size, even if using derivatization by trimethylsilylation to reduce boiling points. 
Molecules profiled by trimethylsilylation GC-MS based metabolomics include amino acids, 
di- and tripeptides, hydroxyl acids, organic phosphates, fatty acids, alcohols, sugar acids, 
mono-, di- and trisaccharides including sugar acids and sugar alcohols, aromatic acids, 
nucleosides and mononucleotides (but not di- or trinucleotides), sterols, polyamines, and a 
large variety of miscellaneous compounds.
BinBase uses a retention index- and mass spectral quality filtering system based on GC-TOF 
based mass spectral deconvolution results as input21 to store and report unique metabolite 
signals that are detected in metabolomic studies. Through the connected MiniX system22, all 
studies in BinBase are associated with metadata such as species, organs, cell types, and 
treatments. The BinBase algorithm has been published previously11,23 and is used over the 
past 13 years. It relies on mass spectral deconvolution of GC-TOF MS data by the Leco 
ChromaTOF software and utilizes a multi-tiered filter system with different settings to 
annotate deconvoluted instrument peak spectra as unique database entries (“bins”). For 
typical studies on mammalian plasma with about 50–60 samples, about 1,000 peaks would 
be detected by ChromaTOF software at least in one chromatogram at signal/noise ratios s/
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n>5. BinBase removes low abundant, inconsistent and noisy peaks that cannot be assigned to 
existing bins in BinBase and that have too low spectra quality to generate a new bin in 
BinBase, resulting in datasets that typically report 400-500 peaks for mammalian plasma 
samples. Compound identifications within BinBase are managed by the administrator using 
spectral libraries and retention index information from the Fiehnlib libraries12 and NIST 
mass spectra. In a typical final BinBase report such as on mammalian plasma, about 30-40% 
of the reported bins are noted as identified metabolites, i.e. about 150 compounds, including 
database identifiers such as KEGG, PubChem and InChI keys.
BinVestigate
BinVestigate is an open-access query tool (http://binvestigate.fiehnlab.ucdavis.edu) to obtain 
information on known/unknown compounds present in BinBase. BinVestigate used data 
from trimethylsilyl-derivatized GC-MS based metabolomics with respect to the frequency, 
intensity and origin of such metabolites. Unknowns can be queried in two ways in 
BinVestigate: (a) users obtain result data from the West Coast Metabolomics Center 
(WCMC) or download public WCMC data from the free NIH database http://
www.metabolomicsworkbench.org18; (b) alternatively, users can match EI-MS spectra 
obtained from own GC-MS datasets against BinBase within narrow Kovats retention index 
windows to gain a Bin ID for cross study analysis. BinVestigate result data are downloaded 
as CSV files and represented by sunburst diagrams. Some information, such as cell line 
genotypes and specific treatments is currently withheld to maintain confidentiality of study 
specifics of WCMC user data. For that reason, the WCMC uploads public data with more 
specific biological details to the NIH MetabolomicsWorkbench.
BinVestigate utilizes MongoDB for data storage and retrieval. The database is accessible and 
extendable by utilizing its REST services and the RSQL query language. To populate the 
MongoDB database, a Spring-based integration workflow is utilized to associate the study 
design information from our in-house study design database MiniX with metabolomic 
information. The metabolome data are contributed by the in-house data processing system 
BinBase that is based in PostgreSQL. Metabolite abundance data are normalized to the 
intensities of the sum of the internal standards (fatty acid methyl esters) in order to level the 
absolute differences between analyses over time. For comparing abundances in the 
BinVestigate sunburst diagrams, it is important to note that a mere 2-fold difference in 
normalized abundances between organs or species should be ignored because such values 
reflect average intensities across biological studies, and hence very much dependent on the 
conditions of such biological studies (e.g. mutants, stress conditions, and other factors that 
may greatly influence metabolite abundances). On the other hand, a 10-fold or 50-fold 
difference in relative intensities certainly qualifies for a high likelihood of different 
metabolite concentrations across different organs or species.
For users who query their own GC-MS mass spectra, Kovats retention indices are computed 
inside the integration workflow to enable access to BinVestigate for the general metabolomic 
community. Mass spectral similarity scores are calculated by the composite measure of the 
NIST algorithm. BinVestigate uses Java and Scala programming languages for data 
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processing, and JavaScript for graphic user interface. Query results are available as JSON 
based documents or XLS compatible csv files. D3JS is utilized for data visualization.
In order to test the usability of BinVestigate, we tested one statistically significant unknown 
that was published by a European group investigating human cytomegalovirus infection24. 
Using similarity search with mass spectrum and retention index, the author’s unknown 
U180424 matched our BinBase unknown ID 8270 (Supplementary Fig. 12), demonstrating 
that BinVestigate is widely applicable for the metabolomics community.
False Discovery Rate (FDR) testing of BinBase
We have tested the BinBase data processing accuracy by determining false positive (FP), 
true positive (TP), false negative (FN) and true negative (TN) spectra annotation rates for the 
five unknown biomarkers highlighted in this research report. We have used the following 
equations:
FDR = FP/ TP+FP (1)
Accuracy = TP+TN / FP+FN + TP + TN (2)
Sensitivity = TP/ TP+FN (3)
Specificity = TN/ TN+FP (4)
For BB106699 (N-methyl-UMP), BinBase stored a total of 324,471 experimental mass 
spectra within the retention index search range. We determined a total 7,363 true positive 
spectra for N-methyl-UMP. For determining false positives, we chose spectra with an ion 
abundance ratio of m/z (352 / 315) > 0.3. We chose this ratio because UMP elutes within the 
retention index window (about 2 seconds later than N-methyl-UMP) and shares most 
fragment ions with N-methyl-UMP, except for m/z 352 that is abundant in UMP but absent 
from N-methyl-UMP (Supplementary Fig. 13). With this criterion, 3 false positive spectra 
were found, a FDR of 0.04%. The number of false negatives should be a lot higher than the 
number of false positives because BinBase was designed to assign ‘known peaks’ in a 
conservative way. Yet, very low abundant spectra as well as very complex chromatograms 
may lead to mass spectral deconvolution errors, leading to false negative peak reports. False 
negatives were defined as spectra in the retention index search range that were not annotated 
as N-methyl-UMP but had m/z ion ratios 169/315 between 10:1 and 1:1 and 169/299 
between 10:1 and 1:1 (i.e. 1.0 to 10.0) and m/z 169 > 30% base peak intensity. With these 
criteria, 1,472 spectra were possible false negatives, yielding an overall sensitivity of 83.3%, 
specificity of 100% and predictive accuracy of 99.4%. We used similar detailed analyses for 
the other four BinBase spectra (Supplementary Table 3).
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A close investigation of histograms and raw chromatograms for BB160842, however, 
yielded a co-elution of N-methyl-alanine and the isomer 2-aminobutyric acid for many 
sample chromatograms. For false positives we used the criterion m/z 218>2% base peak 
intensity, which is an ion that is a typical fragment for alpha-amino acids17. Unfortunately, 
N-methyl-alanine also shows low abundant m/z 218 ions, albeit much less abundant than in 
2-aminobutyric acid. 2-aminobutyric acid shows also most fragments that occur in N-
methyl-alanine (base peak m/z 130, m/z 100, m/z 114, m/z 147, and m/z 204). N-methyl-
alanine presents low abundant diagnostic ions (m/z 144, m/z 142 and m/z 175) that are even 
lower abundant and in different ratios in pure 2-aminobutyric acid. Using these diagnostic 
ions we have validated the detection of pure N-methyl-alanine in biological samples, as well 
as detection of pure 2-aminobutyric acid in other samples. In most chromatograms, however, 
total peak intensities were too small to deconvolute the quantities of both co-eluting 
compounds due to the low abundance of the diagnostic ions. Hence, BB118961 should be 
regarded to reflect a mixture of both compounds in BinVestigate.
MS-DIAL 2.0
MS-DIAL 2.0 is designed as a universal program for MS data processing that supports any 
mass spectrometer, including GC-MS, GC-MS/MS, LC-MS, and LC-MS/MS. It is vendor-
independent by supporting data conversion from file formats of many instrument 
manufactures, namely Agilent, Bruker, Leco, Sciex, Shimadzu, Thermo, and Waters. This 
software also supports any data acquisition method, from nominal or accurate mass analysis 
to data-dependent or data-independent MS/MS. It runs with a user-friendly graphical user 
interface on Windows system (.NET Framework 4.0 or later with at least 4GB RAM 
memory). MS-DIAL 2.0 is freely downloadable at the PRIMe website (http://
prime.psc.riken.jp/) and as Supplementary Software 1.
The summary for processing high resolution GC-MS (GC-HR-MS) data is shown in 
Supplementary Fig. 2, using three primary metabolites as example – glycerol, phosphate, 
and leucine. Peak maxima of these metabolites co-elute within 1.02 s with 3 s peak widths. 
MS-DIAL 2.0 spots all m/z peaks and determines peak spot properties (Supplementary Fig. 
2a) followed by constructing peak groups on the basis of local maxima of the second 
Gaussian filtered array of sharpness values (Supplementary Fig. 2b). The most important 
part is the subsequent chromatogram deconvolution to assign m/z spots, and fractions of 
shared m/z intensities to specific peak groups (Supplementary Fig. 2c). The deconvolution 
follows a least-square regression model based on unique ions, similar to the original MS-
DIAL algorithm13 implemented for data independent MS/MS chromatogram deconvolution. 
The program substantially improved the spectral similarities of all co-eluting metabolites in 
the example data, greatly increasing the number of positively identified metabolites. For 
compound identification, a total of 15,302 GC-MS spectra and 21,770 LC-MS/MS spectra 
are currently available as internal mass spectral database in MS-DIAL 2.0.
Raw data handling and MS-DIAL scalability
The data stream including file formats and converters for MS-DIAL are summarized in 
Supplementary Fig. 4. MS-DIAL can import mzML, netCDF, and Analysis Base Framework 
(ABF) format, while ABF format is recommended for rapid data retrieval and for efficient 
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data access. The ABF file converter is freely available at http://www.reifycs.com/
AbfConverter/index.html. ABF file conversion and compatibility to MS-DIAL have been 
validated for open-access formats like mzML and netCDF, as well as vendor formats from 
Agilent Technologies (.D), Bruker Daltonics (.D), Leco (.netCDF), Sciex (.WIFF), 
Shimadzu (.LCD), Thermo Fisher Scientific (.RAW), and Waters (.RAW).
Peak detection
Profile data are centroided in MS-DIAL 2.0 before peak detection. First, data points are 
smoothed using a linearly weighted smoothing average as default setting. Noise is defined 
by ion amplitude and first and second derivatives. Peak start and end retention times are first 
approximated by noise levels. Then, the local minima within adjacent 5-point windows are 
explored to determine optimal peak start and end times by forward and back tracing. In order 
to avoid defining peak starts and ends too far away from the peak maxima, users can define 
an average peak width (APW) parameter. APW is utilized as a clamp for peak width 
definition within a maximal of ± 2 APW. MS-DIAL 2.0 involves background subtraction for 
filtering out chemical noise (Supplementary Fig. 14). After the initial peak detection 
program finished, the unsmoothed raw chromatogram is retrieved as control. Peaks are 
excluded if the ion abundance of one neighbor point from the peak top is zero, because 
smoothing algorithm may construct signal resembling actual peaks even for 
chromatographic noise. A secondary filter is used to exclude baseline noise arising from a 
sequence of ‘peak-like’ spike noise that may occur when too many peaks are detected in the 
initial peak picking algorithm. Here, the amplitude of spike noise is defined as the difference 
of two adjacent scan points. The current filter will exclude peaks if 4 spike noise signals are 
programmatically detected within a ± 5 APW region of a peak top.
MS1Dec deconvolution
MS-DIAL 2.0 deconvolution, named as MS1Dec, starts with MS1 fragment ions. The peak 
spotting program is first executed over the entire retention time and m/z ranges. In MS-
DIAL, the detected m/z – retention time features are termed ‘peak spots’. The peak quality 
value is defined for each spot by comparing ideal slope values that evaluate the peak 
smoothness, i.e. whether the peak contains any spike noise within its peak width. There are 
three quality levels: high if the ideal slope value is higher than 0.999, middle if the value is 
between 0.9-0.999, low if it is less than 0.9. The peak sharpness value evaluates peak 
symmetry in combination with absolute intensity. The definitions of ideal slope- and peak 
sharpness values followed the previous work13.
Subsequently, all peak spots that have identical peak widths and peak top retention times are 
combined into single arrays. For each array, peak sharpness values are summed up and a 
second Gaussian derivative filter is applied in order to construct ‘peak groups’. The 
smoother is defined by a default sigma value of 0.5 in order to join m/z peak maxima even in 
case of small derivations. In practice, MS-DIAL 2.0 requires at least two scan differences in 
the peak tops of co-eluting metabolites to be distinguished because local maxima of the 
smoothed sharpness arrays are recognized as peak maxima and ignore neighboring peaks.
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The main purpose of deconvolution is to estimate the peak abundance of m/z traces that are 
shared by two or more co-eluting metabolites. This is achieved by defining model peak m/z 
traces in the retention time region of each peak group. High quality m/z traces are utilized to 
construct model peak fitting for each m/z trace by least-square regression. Middle quality 
m/z traces will be used if there are no high quality traces in a focused peak group. Peak 
groups that only consist of low quality traces are recognized as ‘not detected’. In order to 
form the model peak for a peak group, the peak intensities that are above 90% of their base 
peaks are summed for modelling to increase the model accuracy for low ion signals. Peak 
maxima and peak start and end points are determined by tracing the local maximum, left 
local minimum, and right local minimum, respectively.
To deconvolute local model peaks Mt(n), co-eluting adjacent model peaks are considered if 
peak start and end points of the two (or more) model peaks are overlapping. For practical 
reasons, the current program considers up to four co-eluting metabolites (Mt−2(n) and 
Mt−1(n) for the left side of target compound; Mt+1(n) and Mt+2(n) for the right side of target 
compound) for the chromatogram deconvolution of targeted compound Mt(n). Therefore, the 
raw m/z trace C(n) will be decomposed to the model peaks as follows:
C n = aMt − 2 n + bMt − 1 n + cMt n + dMt + 1 n + eMt + 2 n + fn + g
Retention time and full mass spectral similarity
Retention time and mass spectral similarities are used for compound identification and peak 
alignment in the data processing. In order to determine retention time (or index) similarity, a 
Gaussian function is utilized under the assumption that the potential retention time drifts 
between sets of chromatograms will follow Gaussian distribution. MS-DIAL 2.0 uses a 
combined value as ‘full mass spectral similarity’ with weight factor of 2:2:1 for dot product, 
reverse dot product and matched fragment ratio. For calculating overall similarities of 
chromatogram alignments, the software sums up values of retention time and mass spectral 
similarity.
Compound identification
Deconvoluted spectra are matched against mass spectral libraries that are imported as NIST 
MSP format. Library match hits are ranked against experimental data by the total retention 
time (or index) and mass spectral similarities across all samples that are processed in a 
batch. Users can define cut-off thresholds for both parameters. MS-DIAL 2.0 supports two 
retention indices: Kovats RI based on alkanes and Fiehn RI based on fatty acid methyl 
esters.
MS-DIAL aligner
The alignment algorithm for detecting peak groups across all samples of a data processing 
batch was optimized for GC-MS data. The aligner runs in the following procedures: (a) 
creating a reference table; (b) fitting each sample peak table to reference peak table; (c) 
filtering aligned peaks; and (d) missing value interpolation. For LC-MS/MS data, the MS-
DIAL aligner focuses on MS1 precursor ions. While for GC-MS data, the MS-DIAL aligner 
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determines the unique ion used for peak quantification, termed as ‘quant mass’. The m/z of 
highest ion abundance in high quality trace is defined as quant mass in the program, and the 
m/z from middle quality trace will be used if no high quality trace is present. A user-defined 
sample will serve for creating a starting reference table of all deconvoluted peak groups. 
Additional peak groups from further samples are inserted if the total retention and spectral 
similarity between the sample peak groups is lower than a user-defined cut-off compared to 
the existing peak groups in the reference table. This insertion routine is repeated for all 
peaks of all samples. The final table is utilized as the reference peak table for peak 
alignment. Each sample peak table is assigned into the reference peak table as the following 
criterion:
Score = a ∗ RT Similarity + b ∗ MS Similarity
The coefficient a and b can be set by users. After all peaks of all samples are fitted to the 
reference peak table, alignment peak table including RT, quant mass and intensity is 
constructed with each row termed as ‘alignment spot’. The representative quant mass for 
each aligned spot is defined by the consideration of ion abundances- and frequencies of 
quant mass among samples and used for peak height and peak area determination. Average 
retention time (or index) and average quant mass (for accurate mass data) are calculated. A 
‘fill percentage’ with respect to the positive detected sample number in a peak group is 
obtained. The results of compound identification by matching the reference database against 
experimental peak with best retention time and mass spectral similarity are stored. The 
corresponding spectrum for each aligned peak group is retrieved from the imported samples 
for each identified sample peak, or the spectrum with highest total ion intensities for 
unidentified peaks.
The interpolation program for missing values is executed as follows: (1) for the 
quantification mass of each aligned peak group, maximum and minimum retention times (or 
indices) are recorded with maximum and minimum peak widths; (2) for gap filling, local 
maxima and minima signal intensities are determined for the quant mass within the retention 
time (index) window of (minimum RT, maximum RT) ∩ (quant mass average – sigma mass, 
quant mass average + sigma mass); (3) peak height is defined by the amplitude different of 
local maxima and minima, while the corresponding estimated peak area is calculated on the 
basis of average peak width and actual peak maxima.
MS-FINDER 2.0
MS-FINDER 2.0 is launched as a universal program for structure elucidation of unknown 
mass spectra in LC-MS/MS (as previously reported14) and GC-MS. While vendors provide 
specific GC-MS/MS instruments, in practice, we have determined a high degree of in-source 
fragmentation in GC-MS (both hard electron ionization and soft chemical ionization) 
spectra, making the distinction of GC-MS and GC-MS/MS spectra unnecessary here. MS-
FINDER 2.0 is compatible on Windows system (.NET Framework 4.0 or later with at least 8 
GB RAM memory). It is freely downloadable at the PRIMe website (http://
prime.psc.riken.jp/) and as Supplementary Software 2. MS-FINDER 2.0 employs a 
conventional spectral database search function based on dot product, reverse dot product and 
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matched fragment ratio. More importantly, this program features a computational mass 
spectral fragmentation (in silico fragmenter search) for structure annotation. Here, the 
technical detail of in silico fragmenter search for full GC-MS spectra of trimethylsilylated 
(TMS) compounds is described. Additionally, the molecular adduct ions, often the [M]+• or 
[M-CH3]+• radical ions, have to be manually determined by peak alignments in MS-DIAL 
2.0.
Molecular formula generator
Structure elucidation in MS-FINDER 2.0 is started by formula prediction. Full GC-MS 
spectra are mostly ionized compounds with odd electron (radical) ions, denoted as ‘+•’ 
(Supplementary Fig. 5a). This program supports eleven elements for formula generation, 
including carbon (C), hydrogen (H), oxygen (O), nitrogen (N), sulfur (S), phosphorus (P), 
fluorine (F), chlorine (Cl), bromine (Br), iodine (I), and silicon (Si). Atoms CHONSPSi are 
used for program evaluation presented in this paper.
Elemental formulas are computationally generated with valence rules and elemental ratio 
checks. Next, the number of trimethylsilyl (TMS) and methoxy (MeOX) moieties are 
simulated as follows. Here we use formula C22H47N2O9PSi4 as an example (Supplementary 
Fig. 5b). MS-FINDER 2.0 recognizes the origin of all Si elements as TMS moieties. 
Therefore, C22H47N2O9PSi4 is converted to C10H15N2O9P with each C3H8Si subtracted as 
one TMS from the derivatized formula. The number of MeOX moieties is simulated by the 
number of N atoms. All simulated candidates are used as the results of formula generation, 
and hence, C10H15N2O9P (0 MeOX), C9H12NO9P (1 MeOX) and C8H9O9P (2 MeOX) are 
obtained from the original C10H15N2O9P where CH3N is deleted per one N atom.
Molecular formula ranking
Formulas are ranked based on the sum of five diagnostic scores, specifically mass error, 
isotopic ratio error, formula assignment to fragment ions, neutral loss matching, and 
presence of the formula in the combined internal metabolome database. Our ‘existing 
formula database’ is an integrated database to retrieve biologically reported formulas in 15 
repositories (total 90,227 unique formulas) including BMDB, ChEBI, DrugBank, ECMDB, 
FooDB, HMDB, KNApSAcK, PlantCyc, PubChem (Biomolecules), SMPDB, T3DB, 
UNPD, YMDB, STOFF, and MINE. The virtual enzyme expansion database MINE is 
evaluated separately from other repositories. If a formula candidate is present in one of the 
14 databases (except for MINE), the evaluation score is 0.5, otherwise 0. To this value, the 
number of databases that include this formula, standardized by 0.5, is added. After this, 0.2 
is added if the formula is also present in MINE database. The formula database is stored in 
‘.EFD’ file of MS-FINDER folder as ASCII file format.
Searching of structure candidates and in silico derivatization
Currently, MS-FINDER 2.0 has three options to retrieve structural isomers: the internal 
combined metabolome database of 14 repositories with 224,622 unique structures, the 
MINE database with 643,307 unique structures, and the PubChem REST service for 
approximately 70 million structures (Supplementary Fig. 5c). Each repository in the 
combined metabolome database can also be selected by itself. The combined metabolome 
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database and MINE database are stored in ‘.ESD’ and ‘.MSD’ files of MS-FINDER folder 
as ASCII file format.
After the structural data for a given formula is retrieved, the structure is computationally 
derivatized on the basis of the simulated TMS and MeOX numbers using the following 
procedures: (1) the acidic protons attached with heteroatoms ONSP are recognized as the 
reactive protons amenable to TMS derivatization; (2) the carbonyl groups as ketones or 
aldehydes are recognized as reactive ‘C=O’ for MeOX derivatization unless further 
heteroatoms ONSP are attached like carboxylic acids; (3) candidate structures are excluded 
if the number of acidic protons and carbonyl groups is less than the number of simulated 
TMS and MeOX; (4) TMS derivatization is prioritized by OH > COOH > NH2 > SH > 
NHR; (5) MeOX derivatization is prioritized by R1(C=O)R2 > R(C=O)H; (6) identical 
functional groups are derivatized in the same priority, i.e. the order of derivatization is 
determined by the order of atomic numbering.
Ranking of structure candidates
Hydrogen rearrangement (HR) rules (rules P1-P5 and N1-N4 for positive and negative ion 
mode, respectively) have been established to interpret mass spectra of LC-MS/MS with 
collision induced dissociation (CID) as previously reported14. Structure candidates are 
ranked by the integrated score of HR rules, fragment linkage and bond dissociation energy. 
Now, the updated rule-based mass spectral fragmentation library also includes structure 
elucidation for GC-MS spectra. A total of 533 fragment ions are rationalized by m/z, 
formula and SMILES code, and stored in ‘.EIF’ file of MS-FINDER folder as ASCII file 
format. MS-FINDER 2.0 utilizes this rule-based fragmentation library for substructure 
assignments because GC-MS spectra produce intense fragmentation schemes including 
electron shifts, hydrogen rearrangements, homolytic or heterolytic bond cleavages, and 
intramolecular rearrangements, rather than stabilizing fragments by aromatization. This 
program excludes aromatic fragment ions unless the aromatic substructures are detected in 
the original molecules. The likelihood of fragment ion with assigned substructure is 
evaluated by a Gaussian function based on experimental mass errors. Advanced likelihood 
by molecular fingerprints in combination with similarity calculation methods, such as 
Jaccard, will be used in the next version.
For fragment ion without substructure assignment by the rule-based library, in silico spectral 
annotation is performed by simulating an α-cleavage process for up to two bonds with a 
consideration of ± 2 hydrogen rearrangements. To specify the appropriate fragments within 
mass tolerance, computational ions are assigned to observed ions by the following priorities: 
(1) fragments from the first cleavage that differ up to two hydrogens from a neutralized 
substructure; (2) fragments from the second cleavage with assigned precursors in higher m/z 
area; (3) fragments of minimum mass errors. This scoring system is identical to that of LC-
CID-MS/MS spectra except the penalty of HR rules: at current, the HR rules are always 
considered as ‘TRUE’ for GC-MS spectra.
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Performance validation of MS-DIAL 2.0
The scalability and functionality of MS-DIAL 2.0 for GC-MS data processing were 
validated by six raw data files from five major MS vendors (Supplementary Fig. 3 and 
Supplementary Data 1). All raw data files (except Bruker and Thermo) are available at the 
PRIMe website (http://prime.psc.riken.jp/?action=drop_index) with the following data 
sources:
1. LECO GC-TOF(MS): The biological sample was Euglena gracilis; analysis 
procedures were performed according to the ‘LECO GC-TOF MS’ protocol of 
the previous report25.
2. Agilent GC-Q(MS): The biological sample was NIST standard human plasma; 
analysis procedures were performed according to the ‘Agilent GC-Quadrupole 
MS’ protocol of the previous report25.
3. Agilent GC-QTOF(MS): The biological sample was Chlamydomonas 
reinhardtii; analysis procedures were described in ‘Reagents and Sample 
Preparation’ section of this paper.
4. Shimadzu GC-Q(MS): The raw data was distributed from previously reported 
data26.
5. Bruker GC-Q(MS): The raw data was kindly distributed from Bruker Daltonics.
6. Thermo GC-QE(MS): The raw data was kindly distributed from Thermo Fisher 
Scientific.
The MS-DIAL 2.0 data processing procedures were followed by the software tutorial (http://
prime.psc.riken.jp/Metabolomics_Software/MS-DIAL/). The analyzing parameters and MS 
libraries can be downloaded at http://prime.psc.riken.jp/?action=drop_index. The actual 
processing time for nominal and accurate mass GC-MS data were 20–30 sec and 1-2 min, 
respectively. The identification results were manually confirmed by the MS-DIAL 2.0 
graphical user interface.
Performance validation of MS-FINDER 2.0
The performance of MS-FINDER 2.0 for structure elucidation was tested by the accurate 
mass GC-EI-MS spectra of total 441 trimethylsilylated compounds. The sample preparation 
and analytical conditions were described below. For each compound, the molecular mass as 
well as TMS and MeOX number of the derivatized form were determined by manual 
investigation, while the formula, SMILES and InChIKey of the non-derivatized form were 
generated by ChemAxon MolConverter and Calculator (www.chemaxon.com).
The mass tolerance, relative abundance cut off, and isotopic ratio tolerance were set to 0.01 
Da, 1%, and 20%, respectively. The filtering of ‘LEWIS and SENIOR check’ and ‘common 
range for element ratio check’ was activated. The targeted atoms were set to C, H, O, N, S, 
and P as the option of ‘TMS-MeOX derivatized compound’. Tree depth was set to 2, and the 
‘use of fragmentation library for electron ionization’ was applied. For batch process, the top 
100 formula candidates were transferred to the structure searching procedure. The internal 
metabolome database including BMDB, ChEBI, DrugBank, ECMDB, FooDB, HMDB, 
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KNApSAcK, PlantCyc, PubChem (Biomolecules), SMPDB, T3DB, UNPD, YMDB, and 
STOFF were selected for structure searching. PubChem ‘Biomolecules’ were retrieved from 
the ca. 70 million compounds in PubChem by restricting to ‘Biomolecular and interaction 
pathway’, then restricting to ‘Biosystems and pathways’. Currently, 12,400 compounds are 
retrievable from PubChem this way.
MS-FINDER 2.0 was tested by three structure resource sets. The first set is the internal 
metabolome database with 14 repositories as mentioned above, denoted as ‘FINDMetDB’. 
In order to spread search space, MINE and PubChem databases were also included for the 
second and the third set, which were denoted as ‘FINDMetDB+MINE’ and ‘FINDMetDB
+PubChem’. Therefore, the number of total unique structures for the software accuracy test 
were 13,869, 92,628, and 280,245 in ‘FINDMetDB’, ‘FINDMetDB+MINE’, and 
‘FINDMetDB+PubChem’, respectively. The performance test results of MS-FINDER 2.0 
and of ‘random sampling method’ were shown in Supplementary Fig. 6. The logP and 
natural product likeness values were calculated by ChemAxon Calculator 
(www.chemaxon.com) and Natural Product Likeness Calculator (https://sourceforge.net/
projects/np-likeness/). With a mass tolerance of 10 mDa for spectral annotation of CHNOSP 
elements, the probability of finding the correct structure for the top hit, or among the top 3, 
top 5, top 10 hits were 49.2%, 72.1%, 82.1%, and 91.8%, respectively.
Software comparison for MS-DIAL 2.0 and MS-FINDER 2.0
We compared the analyzing results obtained by MS-DIAL 2.0 (version 2.52) and MS-
FINDER 2.0 (version 2.10) against other alternative programs, respectively. For the 
performance of GC-MS chromatogram deconvolution, MS-DIAL 2.0, AMDIS27, 
AnalyzerPro, and ChromaTOF were tested using identical raw data (http://
prime.psc.riken.jp/?action=drop_index). Deconvoluted mass spectra were exported from the 
data processing software and imported to NIST MS Search program (http://
chemdata.nist.gov/mass-spc/ms-search/) to obtain match scores for compound annotation. 
Based on the results of nine primary metabolites from four coeluting peak groups, MS-
DIAL 2.0 outperformed AMDIS, AnalyzerPro and ChromaTOF for most individual spectral 
similarity matches and for the average match scores (Supplementary Table 2).
For the functionality of in silico GC-MS mass spectral annotation, MS-FINDER 2.0, CFM-
ID28, MetFrag29, Molecular Structure Correlator (MSC), and Mass Frontier were evaluated 
using the mass spectra (http://prime.psc.riken.jp/?action=drop_index) of our five BinBase 
unknowns highlighted in this paper with same structure candidate lists that were downloaded 
from PubChem by formula query, computational derivatized and generated in ChemAxon 
Instant JChem (www.chemaxon.com) (Supplementary Table 1). For calculating, scoring and 
ranking 25–59 different isomers, MS-FINDER 2.0 required 2-12 s processing time, similar 
to MetFrag and MSC programs, while CFM-ID and Mass Frontier needed significantly more 
time (5-108 min). More importantly, MS-FINDER 2.0 was the only software that could 
confidently identify the five unknown compounds presented here as top hit; other programs 
had an average ranking of 3.8 (CFM-ID) to 9.6 (Mass Frontier).
The computer condition for data processing was an Intel (R) Core (TM) i7 with 4 GHz CPU 
and 8 GB RAM as Windows 7 System. The settings of MS-DIAL 2.0 and MS-FINDER 2.0 
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were default values as mentioned above. The parameters of other programs are listed as 
follows:
AMDIS: The software application was downloaded from http://chemdata.nist.gov/. 
Match Factor Penalty Level was ‘Very Strong’. Scan Direction was ‘Low to High’. 
Adjacent Peak Subtraction was ‘None’. Resolution, Sensitivity, and Shape 
Requirement were all ‘Medium’.
AnalyzerPro: The software application was purchased from Spectral Works. Data 
processing settings were vendor-suggested default parameters.
ChromaTOF: The software application was purchased from LECO Corporation. Data 
processing settings were vendor-suggested default parameters.
CFM-ID: The web application was performed in http://cfmid.wishartlab.com/. 
Spectra Type was ‘EI’. Number of Results, Mass Tolerance, and Scoring Function 
were 20, 0.01 Da, and Dot Product, respectively.
MetFrag: The web application was performed in http://msbi.ipb-halle.de/MetFrag/. 
Process Mode was ‘[M]’. MZABS and MZPPM were 0.01 Da and 20, respectively.
MSC: The software application was purchased from Agilent Technologies. Data 
processing settings were vendor-suggested default parameters.
Mass Frontier: The software application was purchased from Thermo Fisher 
Scientific. Data processing settings were vendor-suggested default parameters.
Reagents and sample preparation
The following reagents and authentic standard compounds were obtained from (suppliers): 
water, isopropanol, and acetonitrile (Fisher Optima); pyridine (Acros Organics); C8 – C30 
fatty acid methyl esters [FAMEs], methoxyamine hydrochloride [MeOX], ethoxyamine 
hydrochloride [EtOX], N-methyl-N-(trimethylsilyl)-trifluoroacetamide [MSTFA], N-methyl-
N-(trimethyl-d9-silyl)-trifluoroacetamide [MSTFA-d9], ammonium formate, formic acid, 
and N-methyl-L-alanine (Sigma-Aldrich); 2′-O-methyluridine-5′-triphosphate, 3′-O-
methyluridine-5′-triphosphate, 5-methyluridine-5′-triphosphate (TriLink BioTechnologies); 
4-hydroxypropofol-1-O-β-D-glucuronide, and 4-hydroxypropofol-4-O-β-D-glucuronide 
(Toronto Research Chemicals).
All metabolites extraction procedures are kept on ice, the quantities for sample aliquots were 
25 μL for blood plasma, 5×106 for cells, 5 mg for tissues, 2 mL for algae cultures. 
Metabolites were extracted with 1,000 μL degassed acetonitrile:isopropanol:water (3:3:2, 
v/v/v), and then homogenized, centrifuged, decanted, and evaporated. Extracts were cleaned 
by 500 μL degassed acetonitrile:water (1:1, v/v) to remove triglycerides and membrane 
lipids, and evaporated again. For GC-MS analysis, internal standards C8 – C30 FAMEs were 
added to determine the retention index. The dried samples were derivatized with 10 μL 
MeOX (or EtOX) in pyridine and subsequently by 90 μL MSTFA (or MSTFA-d9) for 
trimethylsilylation of acidic protons. For LC-MS analysis, the extracted samples were 
resuspended in 50 μL acetonitrile:water (4:1, v/v) and submitted to instrument.
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Analytical conditions
For gas chromatography – mass spectrometry analysis, the instrumentation used an Agilent 
7890A GC system (Agilent Technologies, Santa Clara, CA, USA) and an Agilent 7200 
accurate mass Q-TOF mass spectrometer (Agilent Technologies, Santa Clara, CA, USA), 
with transfer line temperature maintained at 290 °C. Chromatography was performed on a 
Rxi-5Sil MS column (30m×0.25mm, 0.25μm; Restek Corporation, Bellefonte, PA, USA) 
with Helium (99.999%; Airgas, Radnor, PA, USA) at a constant flow of 1 mL/min. The GC 
temperature program was set as follows: initial temperature of 60 °C with a hold time of 1 
min, a temperature ramp of 10 °C/min to 325 °C, and a final hold time of 9.5 min at 325 °C. 
Injection volume was 1 μL in splitless mode at 250 °C. Mass spectra were acquired from 
m/z 50 to m/z 800 at 5 Hz scan rate and 750 V detector voltage in both electron ionization 
(EI) mode and chemical ionization (CI) mode. Other data acquisition parameters were EI ion 
source temperature 230 °C; EI electron energy, 70 eV; CI ion source temperature 300 °C; CI 
electron energy, 135 eV; CI gas flow rate, 20%; CI gas, Methane (99.999%; Airgas, Radnor, 
PA, USA).
For liquid chromatography – mass spectrometry analysis, the initial separation was achieved 
on an Agilent 1290 infinity LC system (Agilent Technologies, Santa Clara, CA, USA) with 
an Acquity UPLC BEH Amide column (150mm×2.1mm, 1.7μm; Waters Corporation, 
Milford, MA, USA). The mobile phases consisted of (A) 10 mM ammonium formate and 
0.125% formic acid in water and (B) acetonitrile:water (95:5, v/v) with 10 mM ammonium 
formate and 0.125% formic acid. The gradient was 0 min, 100% B; 2 min, 100% B; 7.7 min, 
70% B; 9.5 min, 40% B; 10.3 min, 30% B; 12.8 min, 100% B; 16.8 min, 100% B. A sample 
volume of 2 μL and 5 μL was used for the injection in ESI (+) and ESI (-) respectively, with 
the flow rate of 0.4 mL/min. The autosampler temperature was 4 °C, the column temperature 
was 45 °C. The mass spectrometry was equipped with an Agilent 6530 accurate mass Q-
TOF system (Agilent Technologies, Santa Clara, CA, USA). MS and MS/MS data were 
collected in 4 Hz scan rate and m/z 50–800 mass range. Collision energy was applied at 20 
eV. Mass calibration was maintained at constant infusion of reference ions at m/z 121.0509, 
m/z 922.0098 for positive mode and m/z 119.0363, m/z 966.0007 for negative mode.
Synthetic procedures
Glassware was oven dried at 100 °C overnight prior to the reaction. All reagents were 
purchased from commercial sources (Sigma-Aldrich or Fisher Scientific) and were used 
without further purification unless noted otherwise. Reactions were carried out under an 
atmosphere of dry argon. Liquid reagents were introduced by disposable syringes. Thin layer 
chromatography (TLC) was performed with EMD silica gel 60, F254 precoated TLC plates. 
Short and long wave visualization were performed with a Mineralight multiband ultraviolet 
lamp at 254 and 365 nm, respectively. Flash column chromatography was performed with 
Merck silica gel (Sorbent technologies, 60–200 mesh). Purification of nucleotide mono-
phosphate was performed on a column of Sephadex DEAE-A25. The resin was swollen in 1 
M NaHCO3 at 4°C for 1 day and washed with deionized water before use, unless noted 
otherwise. The fractions containing nucleotide mono-phosphate were identified by Beckman 
DU-7400 UV-Vis scanning spectrophotometer and Applied Biosystems QTrap Mass 
spectrometry.
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N3-methyl uridine synthesis
N3-methyl uridine was synthesized as previously described30,31 with minor modifications. 
In brief, uridine (1.504 g, 6.16 mmol) and K2CO3 (1.704 g, 12.33 mmol) were added to a 
mixture of DMF (7.5 mL) and acetone (7.5 mL). Methyl iodide (383 μL, 6.16 mmol) was 
added dropwise to the suspension. The system was then refluxed for 5 hours. The solvent 
was removed in vacuo. The residue was purified by chromatography on a flash silica 
column. Eluting with (5-10% (v/v) MeOH in CH2Cl2). Fractions containing the product 
were dried in vacuo. Product was recrystallized in MeOH, which yield N3-methyl uridine as 
white crystal.
N3-methyl uridine 5′-mono-phosphate synthesis
N3-methyl uridine 5′-mono-phosphate was synthesized as previously described32 with 
minor modifications. N3-methyl uridine and proton sponge were dried overnight in a 
vacuum oven. Nucleoside (180 mg, 0.69 mmol) was dissolved in freshly distilled trimethyl 
phosphate (8 mL) by heating the solution, and the solution was cooled to −15 °C. Dry proton 
sponge (444 mg, 2.07 mmol) was then added to the solution and the solution was stirred at 
−15 °C for 20 minutes. Distilled phosphorus oxychoride (64 μL, 0.69 mmol) was added 
dropwise under argon with a micro syringe. The reaction solution was then stirred at −15 °C. 
After 2 hours at −15 °C, a solution of 1 M triethylammonium bicarbonate (30 mL, pH 8) 
was added. The clear solution was stirred at room temperature for 45 minutes and freeze 
dried. The crude mixture was dissolved in water and purified using a Sephadex DEAE-A25 
column with a linear gradient of 0.01-0.10 M triethylammonium bicarbonate buffer. 
Fractions containing N3-methyl uridine 5′-mono-phosphate were identified by UV 
spectrophotometer and mass spectrometry. Combined fractions were evaporated under 
reduced pressure yielding N3-methyl uridine 5′-mono-phosphate as white solid.
Data availability
Any Supplementary Information and Source Data files are available in the online version of 
the paper.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Summary for functional and structural identification of unknown metabolites
(a) BinVestigate to search unknown compounds for metabolomics study metadata and 
(nominal) EI-MS spectra in BinBase, with results shown as sunburst diagrams to illustrate 
the biological origin (species, organs, cell types) of unknowns. (b) MS-DIAL 2.0 for 
universal GC-MS or LC-MS/MS deconvolution with high resolution (HR) mass 
spectrometry analytics to obtain the deconvoluted HR-MS spectra of unknowns needed for 
compound identification. (c) MS-FINDER 2.0 for universal GC-EI-MS and LC-ESI-MS/MS 
spectral interpretation to annotate unknowns in combination with the enzyme promiscuity 
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structure database (MINE), resulted in the discovery of biologically significant chemical 
structure. The tools are fully connected in MS-DIAL. Each tool is also available as 
standalone program.
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Figure 2. Metabolomic meta-analysis for origin exploration by BinVestigate
Bin IDs were queried in over 114,000 samples to show cross-study specificity and relevance 
of unknown BinBase ID 160842 (left) and unknown BinBase ID 106699 (right). In the 
sunburst diagrams, the area of the circular sector for each organ (inner cycle) or species 
(outer cycle) was mathematically determined by the average signal intensity of the unknown 
compound when present in such origin. Bin ID, Fiehn RI, Kovats RI, number of annotation 
records, and conclusion of biological significance for the five unknowns discussed in this 
paper were summarized in the table.
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Figure 3. Identification of N-methyl-UMP by MS-DIAL 2.0 and MS-FINDER 2.0
High resolution GC-MS analytics was first used for structure elucidation (left), then LC-
MS/MS was applied as additional evidence line to validate the discovery (right). (a) Spectral 
deconvolution: fragment ions and molecular adduct ions of BinBase ID 106699 were 
deconvoluted and confirmed through MS-DIAL 2.0. (b) Formula prediction and validation: 
C10H15N2O9P was scored and ranked at 1st in MS-FINDER 2.0 based on mass errors, 
isotope ratio errors, and subformula assignments. For GC-MS flow, chemical ionization data 
with different derivatization methods (MSTFA vs. MSTFAd9) were obtained to verify the 
formula as well as to yield the number of acidic protons; for LC-MS flow, between 
theoretical values and experimental values, the mass errors were only 1 mDa, and the 
isotopic ratio errors were within 1%. (c) Structure prediction, validation, and identification: 
structure candidates were retrieved from MINE DB in addition to internal metabolome 
database, and in silico fragmented based on hydrogen rearrangement rules, bond dissociation 
energy, and comprehensive fragmentation rule library (including GC-EI-MS and LC-ESI-
MS/MS). N-methyl-UMP was ranked at the most likely structure in MS-FINDER 2.0 with 
computational assigned substructures. The mass spectra and retention times in GC-MS (left) 
and LC-MS/MS (right) were matched between BinBase ID 106699 in cancer cell sample 
with chemically synthesized N-methyl-UMP standard for final validation.
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